Menu ×

HEALTHCARE & PHARMACEUTICAL

Human Microbiome Market Segmentation by Product (Probiotics, Prebiotics, Diagnostic Tests, Drugs, and Others); by Disease Type (Infectious Disease, Obesity, Diabetes, Gastrointestinal Diseases, Cancer, Cardiovascular Diseases, and Others); by Organism Type (Aerobic Organisms, Obligate & Facultative Anaerobes, Genetically Engineered Strains, BSL-2 & Spore-Forming Species); by Application (Therapeutics, and Diagnostics); and by Technology – Global Demand Analysis & Opportunity Outlook 2021-2031

  • Text Size:

Extensive insights into the Growth of Human Microbiome Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


IN THE NEWS

  • September 2nd, 2020: BiomX Inc. announced that it has entered into a collaboration with Boehringer Ingelheim for the discovery of microbiome-based biomarkers for inflammatory bowel disease (IBD).

  • December 19th, 2017: DuPont Nutrition & Health, the subsidiary of DuPont de Nemours, Inc., announced that it has partnered with APC Microbiome Institute for the creation of a Microbiome Venture so as to advance in the field of new microbiome science-based solutions.

Global Human Microbiome Market Highlights Over 2021 - 2031

The global human microbiome market is estimated to garner a revenue of USD 3251.4 Million by the end of 2031 by growing at a CAGR of 22.3% over the forecast period, i.e., 2022 – 2031. Moreover, in the year 2021, the market generated a revenue of USD 438.3 Million. The growth of the market can be attributed to the increasing research and developments in the field of microbiology and the growing advancements in the field of human microbiome project (HMP). The first phase of the human microbiome project (HMP) research initiative was launched in the year 2007 by the National Institutes of Health (NIH) of the United States so as to improve the understanding of the microbiota involved in human health and disease. Later, in the year 2014, the second phase of the study, which was known as the Integrative Human Microbiome Project (iHMP), was launched with the aim of generating resources to characterize the microbiome. The current understanding of the human microbiome includes 18 studies with 31596 samples and 161265 files advanced search queries according to the statistics by the NIH Human Microbiome Project (HMP) Data Portal. The statistics further stated that 633 samples from buccal mucosa for the study of HMP, 2151 samples from stool, and 13314 samples for FASTQ data from female subjects were collected for the study. Additionally, the growing prevalence of lifestyle-related diseases is also projected to drive the market growth in the coming years.

Human Microbiome Market Graph

Get more information on this report: Request Sample PDF

Global Human Microbiome Market Regional Synopsis

Regionally, the global human microbiome market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is projected to garner the largest revenue of USD 1859.8 Million by the end of 2031, up from a revenue of USD 251.6 Million in the year 2021. The growth of the market in the region can primarily be attributed to the growing expenditure on research and developments (R&D) in the region, presence of a strong healthcare network, along with the surge in initiatives of the governments of the region for promoting research on human health. Besides this, the surge in health expenditure is also expected to add to the market growth in the region during the forecast period. According to the statistics by the World Bank, the current health expenditure as a share of GDP in North America grew from 12.197% in the year 2000 to 16.322% in the year 2019. On the other hand, the market in Europe is projected to register the second-largest revenue of USD 702.3 Million by the end of 2031, up from a revenue of USD 92.9 Million in the year 2021. The market in the region is further segmented by country into Germany, United Kingdom, France, Italy, Spain, Russia, and the Rest of Europe. The market in Germany is projected to garner the largest revenue of USD 169.3 Million by the end of 2031, up from a revenue of USD 21.6 Million in the year 2021.

The study further incorporates Y-O-Y Growth, market opportunities, demand & supply and forecast future opportunity in North America (United States, Canada, Mexico), South America, Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Growth Drivers and Challenges Impacting the Growth of the Global Human Microbiome Market

Growth Drivers

  • Increasing Focus on the Development of Human Microbiome Therapeutics
  • Rising Prevalence of Lifestyle-Related Diseases

Challenges

  • Stringent Government Regulations

Global Human Microbiome Market Segmentation Synopsis

The global human microbiome market is segmented by product into probiotics, prebiotics, diagnostic tests, drugs, and others. Out of these, the probiotics segment is anticipated to garner the largest revenue of USD 1427.7 Million by the end of 2031, up from a revenue of USD 187.2 Million in the year 2021. By disease type, the market is segmented into infectious disease, obesity, diabetes, gastrointestinal diseases, cancer, cardiovascular diseases, and others. Out of these, the gastrointestinal diseases segment is projected to garner the largest revenue of USD 976.2 Million by the end of 2031, up from a revenue of USD 128.2 Million in the year 2021. By organism type, the market is segmented into aerobic organisms, obligative & facultative anaerobes, genetically engineered strains, BSL-2 & spore-forming species, and others. Out of these, the obligate & facultative anaerobes segment is projected to garner the largest revenue of USD 1233.3 Million by the end of 2031, up from a revenue of USD 168.0 Million in the year 2021. By application, the market is segmented into therapeutics and diagnostics, out of which, the therapeutics segment is projected to grow with the highest CAGR of 23.5% during the forecast period. By technology, the market is segmented into genomics, proteomics, and metabolomics. Out of these, the genomics segment is projected to garner the largest revenue of USD 1916.9 Million in the year 2021

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global human microbiome market that are included in our report are Seres Therapeutics, Inc., Evelo Biosciences, Inc., Synlogic, SECOND GENOME, Synthetic Biologics, Inc., YSOPIA Bioscience, 4D pharma plc, DuPont de Nemours, Inc., BiomX Inc., Sun Genomics, Inc., Viome Life Sciences, Inc., and others.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
  • The report includes detailed company profiles of the major players dominating the market.
  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

FREQUENTLY ASKED QUESTIONS

  1. Market Definition
  2. Assumptions & Acronyms
  3. Research Methodology
  4. Executive Summary
  5. Market Dynamics
  6. Value Chain Analysis
  7. Regulatory & Standards Landscape
  8. Industry Risk Analysis
  9. Impact of COVID-19 on the Human Microbiome Market
  10. Analysis of Upcoming Human Microbiome Projects
  11. Analysis of Therapeutic Products
    1. Product Type
    2. Pros
    3. Cons
  12. Pipeline Analysis
  13. Analysis on Skin Microbiome-Focused Products
  14. Product Feature Analysis
  15. Competitive Landscape
    1. Market Share Analysis, 2021
    2. Seres Therapeutics, Inc.
      1. Detailed Overview
      2. Assessment of Key Offering
      3. Predictive Strategies & Positioning vs. Current Positioning
      4. Analysis on Growth Strategies
      5. Exhaustive Analysis on Key Financial Indicators
      6. Recent Developments
    3. Evelo Biosciences, Inc.
    4. Synlogic
    5. SECOND GENOME
    6. Synthetic Biologics, Inc.
    7. YSOPIA Bioscience
    8. 4D pharma plc
    9. DuPont de Nemours, Inc.
    10. BiomX Inc.
    11. Sun Genomics, Inc.
    12. Viome Life Sciences, Inc.
  16. Global Human Microbiome Market
    1. Market Overview
    2. By Value (USD Million)
    3. Market Segmentation
      1. By Product
        1. Probiotics
        2. Prebiotics
        3. Diagnostic Tests
        4. Drugs
        5. Others
      2. By Disease Type
        1. Infectious Disease
        2. Obesity
        3. Diabetes
        4. Gastrointestinal Diseases
        5. Cancer
        6. Cardiovascular Diseases
        7. Others
      3. By Organism Type
        1. Aerobic Organisms
        2. Obligate & Facultative Anaerobes
        3. Genetically Engineered Strains
        4. BSL-2 & Spore-Forming Species
        5. Others
      4. By Application
        1. Therapeutics
          1. Single Strains or Multi-Strain Consortia
          2. Liquid or Dried Bulk Drug Susbtance
          3. Solid Oral Dose
          4. Other Drug Product Finished Dosage Forms
        2. Diagnostics
      5. By Technology
        1. Genomics
          1. Sequencing
            1. Whole Genome Sequencing
            2. 16s rRNA Sequencing Method
            3. Shotgun Metagenomics Sequencing
            4. Others
          2. Polymerase Chain Reaction
          3. Other Genomic Techniques
        2. Proteomics
        3. Metabolomics
      6. By Region
        1. North America
        2. Europe
        3. Asia Pacific
        4. Latin America
        5. Middle East & Africa
  17. North America Human Microbiome Market
    1. Market Overview
    2. By Value (USD Million)
    3. Market Segmentation
      1. By Product
        1. Probiotics
        2. Prebiotics
        3. Diagnostic Tests
        4. Drugs
        5. Others
      2. By Disease Type
        1. Infectious Disease
        2. Obesity
        3. Diabetes
        4. Gastrointestinal Diseases
        5. Cancer
        6. Cardiovascular Diseases
        7. Others
      3. By Organism Type
        1. Aerobic Organisms
        2. Obligate & Facultative Anaerobes
        3. Genetically Engineered Strains
        4. BSL-2 & Spore-Forming Species
        5. Others
      4. By Application
        1. Therapeutics
          1. Single Strains or Multi-Strain Consortia
          2. Liquid or Dried Bulk Drug Susbtance
          3. Solid Oral Dose
          4. Other Drug Product Finished Dosage Forms
        2. Diagnostics
      5. By Technology
        1. Genomics
          1. Sequencing
            1. Whole Genome Sequencing
            2. 16s rRNA Sequencing Method
            3. Shotgun Metagenomics Sequencing
            4. Others
          2. Polymerase Chain Reaction
          3. Other Genomic Techniques
        2. Proteomics
        3. Metabolomics
      6. By Country
        1. United States
        2. Canada
  18. Europe Human Microbiome Market
    1. Market Overview
    2. By Value (USD Million)
    3. Market Segmentation
      1. By Product
      2. By Disease Type
      3. By Organism Type
      4. By Application
      5. By Technology
      6. By Country
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Rest of Europe
  19. Asia Pacific Human Microbiome Market
    1. Market Overview
    2. By Value (USD Million)
    3. Market Segmentation
      1. By Product
      2. By Disease Type
      3. By Organism Type
      4. By Application
      5. By Technology
      6. By Country
        1. China
        2. Japan
        3. South Korea
        4. Australia
        5. India
        6. Singapore
        7. Rest of APAC
  20. Latin America Human Microbiome Market
    1. Market Overview
    2. By Value (USD Million)
    3. Market Segmentation
      1. By Product
      2. By Disease Type
      3. By Organism Type
      4. By Application
      5. By Technology
      6. By Country
        1. Brazil
        2. Argentina
        3. Mexico
        4. Rest of Latin America
  21. Middle East & Africa Human Microbiome Market
    1. Market Overview
    2. By Value (USD Million)
    3. Market Segmentation
      1. By Product
      2. By Disease Type
      3. By Organism Type
      4. By Application
      5. By Technology
      6. By Country
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved